The objective of the MEDIAN Group lab is to evaluate and establish innovative and future-oriented products and technologies to improve the quality of treatment. As innovative technologies are not only increasingly affecting our everyday lives, they also have the potential to contribute to the sustainable and effective treatment of patients.
To this end, the MEDIAN Group lab applies a specially developed process to test, evaluate and identify potential products and technologies. It is important that these innovations are always assessed in terms of their rehabilitative benefits, i.e. their possible integration into everyday clinical practice and their potential to improve the quality of treatment and care.
- Promising concepts are piloted and evaluated in order to be able to make a decision about their possible use, also in collaboration with other treatments and therapies.
- Further projects are maintained in a database and tested for their practical benefits in a specific clinical scenario at a MEDIAN Group facility.
Projects
VR-Therapy in anxiety disorders
Virtual reality (VR) exposure therapy in the treatment of anxiety disorders and specific phobias.
Projects
VR-Therapie in addiction
Virtual reality (VR) exposure therapy for the treatment of substance-related and non-substance-related addictions.
Projects
AI-guided neurological therapy
Tablet app as a digital aid in the therapy for language, cognition and everyday skills.
Projects
VR therapy in neurology
Effective training to improve physical skills and cognitive functions.
Projects
Voice Profiling in mental health servives
Voice biomarkers for an objective measurement of psychological symptoms.
